Yüklüyor......
Current paradigms and Evolving concepts in metastatic castration-resistant prostate cancer
Until recently, docetaxel-based therapy represented the only therapy shown to prolong survival in patients with metastatic castration-resistant prostate cancer (mCRPC). The past year and a half has been marked by unprecedented progress in treatments for this disease. Three positive phase III clinica...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Nature Publishing Group
2011
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3449061/ https://ncbi.nlm.nih.gov/pubmed/21602834 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/aja.2011.35 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|